CLOVER HEALTH INVESTMENTS CO

Clover Health Investments (CLOV) dips below its 200‑day SMA, trading at $4.78 amid low liquidity and modest earnings; investors await regulatory shifts and strategic moves to boost confidence.

Explore Clover Health’s October 21 performance: $4.80 closing, 24‑hr drop, $2.4B cap, and a 200‑day SMA of $3.45.

Clove Health’s share price drops to $4.72; analysts expect a modest EPS loss but rising revenue ahead of the November 4 earnings call.